Orthofix Medical Inc. (OFIX) Stock

Orthofix Medical Inc. (OFIX) is a Healthcare stock trading at $10.01 (as of 2026-08-20), with a market capitalization of $404.62M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Orthofix Medical Inc. is a medical device and biologics company that designs, develops, and markets orthopedic and spine-related products and biologics. It operates through Global Spine and Global Orthopedics segments and sells through direct sales representatives and independent distributors and sales representatives to healthcare providers.

Understand Orthofix Medical Inc.: how it makes money

Orthofix Medical Inc. makes and sells medical devices and biologics for spine and orthopedic patients, and it monetizes through sales of bone growth stimulator devices, motion preservation and fixation implant products, and related support services.

The profit engine is the conversion of enabling technology adoption into broader spinal implant and ortho biologics utilization, which then drives Global Spine net sales.

Revenue by segment (latest quarter)
Spine$0.2B
Ortho$0.0B

Business quality (Weak): High reported gross margin (70.9%) alongside a negative operating margin (-7.3%) suggests that while product economics look strong, operating expenses or investment are not yet translating into operating profit.

Bull case

  • Strong gross margin: Gross margin is 70.9% for the quarter, indicating meaningful gross profit generation potential from its product and services mix.
  • Global Spine is the core revenue driver: Global Spine net sales are 0.16 USD_B versus Global Orthopedics at 0.03 USD_B.

Bear case

  • Operating losses: Operating margin is -7.3%, indicating the company is not profitable at the operating level in the latest reported quarter.
  • International pressure in orthopedics: International Orthopedics net sales decline is reported as 2.0%.
  • Limited scale of certain demand metrics: Seven-Demand Units placed are 6.0, versus Enabling Technology Units placed of 1070.0, which may indicate slower adoption of the demand-side offering relative to enabling technology.
Valuation — source: SEC EDGAR (first-party)
Price$10.01
Market Cap$404.62M
Price / Book0.93
Price / Sales0.51
FCF Yield-22.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$822.31M
Net Margin-11.2%
Revenue Growth (YoY)2.9%
EPS Growth (YoY)-29.4%
FCF Growth (YoY)-85.9%
Financial Health — source: SEC EDGAR
Altman Z-Score0.99 (distress)
Piotroski F-Score5/9 (moderate)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.6
Industry P/E (Medical Equipment)32.9
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderEngine Capital Management, LP ($50.36M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOMassimo Calafiore
Employees1,616
CountryUS
IPO Date1992-04-24

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Tactile Systems Technology, Inc. (TCMD)
  • NeuroPace, Inc. (NPCE)
  • ClearPoint Neuro, Inc. (CLPT)
  • SHOULDER INNOVATIONS, INC. (SI)
  • Sight Sciences, Inc. (SGHT)
  • CARLSMED, INC. (CARL)
  • Mobia Medical, Inc. (MOBI)
  • TriSalus Life Sciences, Inc. (TLSI)
OFIX earnings history · OFIX institutional & insider holders · OFIX KPIs & operating metrics · OFIX financials · OFIX investor presentations & press releases · OFIX SEC filings · OFIX peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.